smart assessment of the “health@home” opportunity
TRANSCRIPT
Smart Assessment of the “Health@Home” OpportunityOctober 5, 2021
Speakers and moderators
Don McDanielCEOCanton & Company
Brent Feorene, MBAExecutive DirectorAmerican Academy of Home Care Medicine
Eliza Pippa Shulman, DO, MPHChief Medical OfficerMedically Home
William Streck, MDChief Clinical OfficerCanton & Company
Michael RoseVP, MarketingCanton & Company
StrongManagement,GeographyAttractPrivateEquityInvestorstoHospices
Hospice News, 2021
In the news
withAddedFlexibilities,NewEntrants
Hospital@HomeGainsMomentum
American Hospital Association, 2020
SNF@HomeModelBecoming
‘CriticalPlayer’forSuccess
Skilled Nursing News, 2021 AT-HOMEDIALYSISONTHERISE
Managed Healthcare Executive, 2021
mHealthIntelligence, 2021
VA Plans $1B Expansion of Remote Patient Monitoring Platform
The “health@home” phenomenon
health@home
Traditional home health
Home care medicine
Telehealth
Hospital at home
Palliative care / hospice at home
ICU at home
Home infusion
SNF at home
Dialysis at home
Virtual care and remote patient monitoring (RPM)
Chronic care management (CCM)
The opportunity size
Sources: MarketsAndMarkets, All The Research, Mordor Intelligence, Grandview Research, Market Data Forecast
Hospital@Home ICU@Home Infusion@Home
U.S. VALUATION $101.2B 2020
CAGR 7.9% 2020 – 2027
GLOBAL VALUATION $3.35B 2020
CAGR 85% 2021 – 2026
U.S. VALUATION $19.28B 2020
CAGR 10.9% 2021 – 2028
General Telehealth Remote Patient Monitoring
Chronic Care Management
U.S. VALUATION $3.5B 2020
CAGR 9.61% 2020 – 2028
U.S. VALUATION $975M 2020
CAGR 32.8% 2021 – 2025
GLOBAL VALUATION $12.6B 2021
CAGR 11.4% 2021 – 2026
Q&A
